ArticleScientific reports2025
Metal-organic framework (Pd-DTPA-MOF)-based materials as heterogeneous catalysts for C-S cross-coupling reactions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report highlights the development of an innovative and efficient metal-organic framework (MOF) synthesized through a hydrothermal reaction utilizing palladium acetate salt and DTPA as the organic ligand. Detailed analyses of the synthesized MOF were performed using techniques such as FT-IR, TGA, XRD, EDS, BET, SEM, and ICP. The resulting Pd-DTPA-MOF demonstrated exceptional efficiency and performance in C-S cross-coupling reactions under mild conditions. Additionally, this nanostructured material offers multiple benefits, including high product yields, a simple synthesis process, and environmentally friendly characteristics. Importantly, the versatile Pd-DTPA-MOF nanocatalyst can be easily recovered from the reaction mixture via centrifugation and reused for up to four consecutive cycles with only a slight decline in catalytic activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.